V
Vifor Pharma AG
SIX:VIFN
Vifor Pharma AG
SIX:VIFN
Price:
166.15 CHF
0.48%
Market Closed
Updated:
May 21, 2024
Vifor Pharma AG
Income to Minority Interest
|
Vifor Pharma AG
Income to Minority Interest Peer Comparison
Comparables:
NOVN
NLSP
ROG
S
SDZ
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
V
|
Vifor Pharma AG
SIX:VIFN
|
Income to Minority Interest
-CHf118.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-14%
|
|
|
Novartis AG
SIX:NOVN
|
Income to Minority Interest
-$4m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
29%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Roche Holding AG
SIX:ROG
|
Income to Minority Interest
-CHf860m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-15%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Income to Minority Interest
-$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vifor Pharma AG's Income to Minority Interest?
Income to Minority Interest
-118.8m
CHF
-118.8m
CHF
Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Income to Minority Interest amounts to -118.8m CHF.
What is Vifor Pharma AG's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 10Y
-14%
-14%
Over the last year, the Income to Minority Interest growth was -20%. The average annual Income to Minority Interest growth rates for Vifor Pharma AG have been -9% over the past three years , -8% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
